Scientists find new streptococcus variant causing severe infections
15 July 2015 | By Victoria White
Scientists have discovered a new subtype of emm89 streptococcus that has contributed to a rise in disease cases in the UK over the last 17 years...
List view / Grid view
News
Oxford Vaccine Group initiates Phase 2 study of Ebola prime-boost vaccine regimen combining MVA-BN-Filo and Ad26.ZEBOV
15 July 2015 | By Victoria White
Oxford Vaccine Group has initiated a Phase 2 clinical study of the Ebola prime-boost vaccine regimen that combines MVA-BN-Filo with Ad26.ZEBOV...
Sanofi announces new Global Business Unit structure
15 July 2015 | By Victoria White
Sanofi plans to evolve its business with the creation of five Global Business Units: General Medicines & Emerging Markets, Specialty Care, Diabetes & Cardiovascular, Sanofi Pasteur and Merial.
Anti-hypertensive therapeutics market value in Asia-Pacific to approach $20 billion by 2021, says GBI Research
15 July 2015 | By Victoria White
The anti-hypertensive therapeutics market in the Asia-Pacific will expand in value from $15.7b in 2014 to reach $19.9b by 2021, says GBI Research...
Takeda submits NDA in the US for ixazomib for the treatment of multiple myeloma
15 July 2015 | By Victoria White
Takeda has submitted an NDA to the US FDA for ixazomib for the treatment of patients with relapsed and/or refractory multiple myeloma...
Mylan and Dr Reddy’s launch Memantine hydrochloride tablets in the US
15 July 2015 | By Victoria White
Both Mylan and Dr. Reddy's have launched Memantine hydrochloride tablets USP, 5 mg and 10 mg, which is the generic version of Namenda Tablets, in the US...
Celgene to acquire Receptos for $7.2 billion
15 July 2015 | By Victoria White
Celgene and Receptos have signed a definitive agreement in which Celgene has agreed to acquire Receptos for approximately $7.2 billion...
Lilly Diabetes launches Android version of Glucagon Mobile app
15 July 2015 | By Victoria White
Lilly has released an Android version of its Glucagon Mobile application designed for caregivers and healthcare providers who support people with diabetes...
Quotient Clinical announces expansion of pharmaceutical sciences capacity
14 July 2015 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® Company, has announced a significant expansion of its pharmaceutical sciences capabilities...
Digital evolution for ground-breaking Yellow Card Scheme
14 July 2015 | By Victoria White
Fifty years on from its inception, the UK Yellow Card Scheme is moving into the digital age through a free-access mobile app...
Soliris could drive myasthenia gravis treatment market value beyond $550 million by 2024, says GlobalData
14 July 2015 | By Victoria White
The global market for myasthenia gravis therapeutics is anticipated to more than treble in value from $146.4 million in 2014 to $550.4 million by 2024...
EU approves Gadovist for use in paediatric patients less than 2 years of age
14 July 2015 | By Victoria White
Bayer's Gadovist has received a label extension in the EU for diagnostic use with MRI or MRA in paediatric patients less than 2 years of age...
Sanofi Pasteur ships first 2015-2016 seasonal influenza vaccine doses in US
14 July 2015 | By Victoria White
The FDA has released the first doses of Sanofi Pasteur’s Fluzone influenza vaccine for shipment for the 2015-2016 influenza season in the US...
Quotient Clinical acquires second GMP manufacturing facility
14 July 2015 | By Victoria White
Quotient Clinical is to expand its pharmaceutical sciences capabilities. This includes the acquisition of a second GMP manufacturing facility...
Ferrer initiates Phase IIa clinical study of Lorediplon in patients with insomnia
14 July 2015 | By Victoria White
The first patient has been recruited into a Phase IIa clinical trial to test the efficacy, safety and tolerability profile of Lorediplon in insomnia...
